ČASOPIS ČESKÉ FARMACEUTICKÉ SPOLEČNOSTI A SLOVENSKÉ FARMACEUTICKÉ SPOLEČNOSTI

Instructions for Authors for Submitting Contributions to the Journal Česká a slovenská farmacie

Česká a slovenská farmacie publishes, upon positive review by peer reviewers or after modifications according to their comments, reviews, expert communications, and original works related to pharmacy or healthcare. It also publishes articles on the history of pharmacy and healthcare, contributions from pharmaceutical practice, reports on the activities of pharmaceutical societies, conferences, symposia, and other important events.

The journal accepts contributions for the following sections:

Opening Word

Maximum length: 2 pages.

Current Pharmacotherapy

Drug profiles, pharmaceutical groups, side effects, case studies, postgraduate education, interactions, counseling, etc.

Given the practical focus of the journal, please ensure the contribution is written in an understandable manner, with an emphasis on applying the provided information in practice. The work should primarily focus on treatment. Please include over-the-counter medications (OTC) or an overview of individual active substances and products (e.g., in a table) with usual dosing for the indication.

Recommended length: max. 10 pages.

Medicamenta Nova

Article structure: classification of the drug group, chemical structure, mechanism of action, indications, contraindications, side effects, dosage, interactions.

Recommended length: max. 8 pages.

Medicinal Plants and Nutraceuticals

Emphasis on publishing evidence-based medicine information in the field of medicinal plants and nutraceuticals.

Recommended length: max. 6 pages.

Self-Medication

Texts focused on the sale of OTC medicines or dietary supplements and the role of pharmacists and pharmacy assistants in their dispensing.

Due to the journal's practical focus, please ensure that the contribution is clear, with an emphasis on the practical use of the provided information. The work should primarily focus on treatment. Please include OTC drugs or an overview of individual active ingredients and products (e.g., in a table) with usual dosing for the indication.

Recommended length: max. 8 pages.

Hospital Pharmacy

Positive drug lists, drug commissions, information activities, educational programs for patients, concepts, etc.

Recommended length: max. 8 pages.

Case Studies from Pharmaceutical Practice

Work of pharmacists at the patient's bedside, dispensing activities, medication records of patients, etc.

Communications from practice (case study, pictorial case study, “how I do it”). We welcome evidence-based case studies with the following structure:

  • Case description and formulation of the question.
  • Literature search with sources and methods described.
  • Answering the clinical question.
  • Critical evaluation of the literature.
  • Application to the specific case.

Recommended length: max. 8 pages.

Pharmaceutical Technology

Drug preparation in pharmacies, news in the field of dosage forms.

Recommended length: max. 8 pages.

Medical Devices

Recommended length: max. 8 pages.

Review Article

Required structure: introduction, objective, methodology (including detailed search strategy), discussion, conclusion.

Recommended length: max. 12 pages.

For Clinical Pharmacy Practice

Recommended length: max. 8 pages.

Original Work

Required structure: introduction, objective, methodology (including statistical methods), discussion, conclusion.

Recommended length: max. 12 pages.

Social Pharmacy and Pharmacy Practice

Drugs and society, psychology, public opinion surveys, international perspectives, pharmacist vs. patient, physician, health insurance, pharmaceutical company, information from the pharmacy sector.

Recommended length: max. 8 pages.

Reports

Recommended length: max. 4 pages.

History of Pharmacy and Healthcare

Recommended length: max. 6 pages.

Manuscript preparation

Please write your contribution using a standard word processor, following these technical guidelines:

  • Recommended font: Times New Roman.
  • Recommended font size: 12, line spacing 1.5.
  • Use the "Enter" key only at the end of paragraphs, not at the end of each line.
  • Structure the article into smaller, more readable sections.
  • Adhere to correct drug name usage — find basic rules here.
  • Distinguish between numerals 1 and 0 and letters l and O.
  • Use round brackets ( ).
  • Never insert a space before punctuation marks; always put a space after.
  • Separate units of measure from values with a space; use SI units.
  • Always explain abbreviations when first introduced; avoid abbreviations in titles.
  • Use either the Czech/Slovak spelling or the original Latin form for foreign terms.
  • Avoid common mistakes—a list is available here.

Manuscript components

1. A clear title, names and degrees of all authors, and their affiliations

The postal address of the corresponding author, including phone number and email (correspondence details are part of the article).

2. Abstract

A brief summary of the content, up to 20 lines. A structured format (introduction, objective, methodology, results, conclusion) is preferred.

3. Keywords

3–6 keywords, except for sections labeled "Information" (use terms from the Index Medicus list is recommended).

4. English translation of the article’s title, abstract, and keywords

5. Main Text

For long articles, use subheadings to improve readability. Avoid using automatic text corrections. Use only standard abbreviations and avoid them in the title, abstract, and keywords. Full terms should precede any abbreviation (except standard unit abbreviations). Abbreviations should be consistently based on Czech/Slovak or English terms.

The text should include the benefit for pharmacy practice or specify how pharmacists can be involved.

6. Figures and Tables

Numbered and labeled in high quality suitable for printing. Make sure each figure is referenced in the text. All commonly used image formats are accepted. Large files can be sent via a file-sharing service. Individual arrangements can be made for adjusting images.

For reprinted illustrations, indicate the original source and provide written permission from the copyright holder.

7. References

Number references in order of appearance in the text, using numbered parentheses. Prefer up to 20 citations. “Personal communications” or “unpublished observations” should be placed in parentheses in the text and not in the reference list. For references to unpublished but accepted works, indicate the journal with "Forthcoming" or "In press," and obtain permission to cite and confirm acceptance for publication. Format citations according to the examples provided (see also here). Journal names should be abbreviated per the style used in Index Medicus and include the issue number.

Examples of Citations

Journal Article:

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.

Book:

Kolář J, Zídková H. Nárys kostní radiodiagnostiky. Prague: Avicenum; 1986.

Book Chapter:

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

Proceedings Article:

Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, et al., editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.

Dissertation:

Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation]. Mount Pleasant (MI): Central Michigan University; 2002.

Internet Article:

Knopová M. Bezpečnost dat v informačních systémech. Ikaros [Internet]. 2011;15(6) [cited 2011 Jun 14]. Available from: http://www.ikaros.cz/node/6946.

Submitting the manuscript

  • Submit the manuscript electronically to dostalova@solen.cz.
  • Only original works not published or under review elsewhere will be accepted. State this in your cover letter. The legal relationship between the publisher and the author is governed by the Copyright Act.
  • Language of the contributions: Czech, Slovak, or English. The work will be printed in the submitted language.
  • Editing: The editors reserve the right to make minor language and stylistic edits. If the manuscript needs to be shortened, the author’s consent will be sought. The author will receive a proof for corrections before final printing.
  • Peer Review: Articles undergo a double-blind peer review process. The editorial board decides on acceptance based on the review. The corresponding author will be informed of acceptance or rejection.
  • No fee is charged for publishing articles supported by grants or other public funding, nor for English language proofreading.
  • There is no legal entitlement to remuneration for publications or for preparing review reports.
  • By submitting an article, the author grants the publisher an exclusive license for reproduction and distribution of the work in print in the Czech Republic and abroad, including sublicensing rights, under § 56 of the Copyright Act, and for internet use under § 18 of the Copyright Act.

Česká a slovenská farmacie

Vážená paní, pane,
upozorňujeme Vás, že webové stránky, na které hodláte vstoupit, nejsou určeny široké veřejnosti, neboť obsahují odborné informace o léčivých přípravcích, včetně reklamních sdělení, vztahující se k léčivým přípravkům. Tyto informace a sdělení jsou určena výhradně odborníkům dle §2a zákona č.40/1995 Sb., tedy osobám oprávněným léčivé přípravky předepisovat nebo vydávat (dále jen odborník).
Vezměte v potaz, že nejste-li odborník, vystavujete se riziku ohrožení svého zdraví, popřípadě i zdraví dalších osob, pokud byste získané informace nesprávně pochopil(a) či interpretoval(a), a to zejména reklamní sdělení, která mohou být součástí těchto stránek, či je využil(a) pro stanovení vlastní diagnózy nebo léčebného postupu, ať už ve vztahu k sobě osobně nebo ve vztahu k dalším osobám.

Prohlašuji:

  1. že jsem se s výše uvedeným poučením seznámil(a),
  2. že jsem odborníkem ve smyslu zákona č.40/1995 Sb. o regulaci reklamy v platném znění a jsem si vědom(a) rizik, kterým by se jiná osoba než odborník vstupem na tyto stránky vystavovala.


Ne

Ano

Pokud vaše prohlášení není pravdivé, upozorňujeme Vás,
že se vystavujete riziku ohrožení svého zdraví, popřípadě i zdraví dalších osob.